ANNOUNCEMENT
New Member – Dr. Joaquim Caner
March 17, 2025

Dr. Joaquim Caner
Credits: WPI-Bio2Q
Introducing new member of Bio2Q
We are delighted to welcome Dr. Joaquim Caner as a Postdoctoral Fellow at Bio-1 Core of Bio2Q.
The greeting from Dr. Caner is as follows.
“After transitioning from medicinal chemistry to photocatalysis, I am excited to join the Bio2Q research community under the leadership of Prof. Makoto Arita to explore the integration of organic chemistry with cutting-edge biomedical applications. My current research focuses on synthesizing potential gut microbiota-derived ‘dark matter’ metabolites, their precursors, and stable isotope-labeled (SIL) analogs. These compounds are crucial for metabolomics, drug discovery, and mechanistic studies, helping to uncover metabolic pathways, trace biochemical transformations, and enhance our understanding of health and disease.
In particular, stable isotope-labeled compounds serve as powerful probes that enable high- resolution metabolic flux analysis and quantitative metabolomics, offering unparalleled insights into the dynamics of metabolic processes.
By integrating chemical synthesis with bioinformatics, computational modeling, and biomedical sciences, I aim to enhance the structural elucidation and analysis of relevant biologically active compounds to later design a new class of gut microbiota-related drugs.
I look forward to collaborating with interdisciplinary teams at Bio2Q to expand the applications of my research. By combining experimental and computational approaches, we aim to refine our understanding of gut microbiota-host crosstalk, ultimately contributing to Bio2Q’s mission of advancing metabolomics and biomedical sciences.”
More Bio2Q News
Newsletter “Bio2Q Connect” (Vol. 2, Issue 8)
We are delighted to share with you Vol. 2, Issue 8 of WPI-Bio2Q Newsletter "Bio2Q Connect". Major topics of this issue include: Bio2Q ...
[Publication] Neuromodulation by the immune system: implications for brain-direc...
Co-authored by a Bio2Q researcher, this Review explores how the brain-immune axis acts as a key regulator of brain function and behavior thr...
【Seminar】WPI-Bio2Q Open Seminar: Kazuki Nagashima, MD-PhD
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event for faculty, ...
[Publication] Mammalian Tolerance to Amino Acid Heterochirality
Co-authored by Bio2Q and Keio University researchers, this Review explores the role of D-amino acids in mammals, highlighting their function...
【Seminar】WPI-Bio2Q Open Seminar: Jianguo Xia, Ph.D.
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This is an event for faculty, ...